Veraxa Biotech AG - Post de-SPAC reported asset growth of 4.50% for the quarter ended Dec 2025. These growth metrics cover 1 quarter of results, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2025 |
|---|---|
| Growth Ratios | |
| Assets Growth (1y) | 4.50% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | -67.01% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 10.90% |
| Total Debt Growth (1y) | 103.52% |